Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cerilliant
US Department of Justice
Mallinckrodt
Deloitte
Harvard Business School
Boehringer Ingelheim
Farmers Insurance
Queensland Health

Generated: April 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 9,044,480

« Back to Dashboard

Summary for Patent: 9,044,480
Title:Compositions and methods for treating HCV
Abstract: The present invention features methods of using Compound I to suppress HCV mutants, treat treatment-experienced HCV patients, and treat HCV patients having non-CC IL28B rs12979860 genotype.
Inventor(s): Pilot-Matias; Tami (Green Oaks, IL), Gaultier; Isabelle A. (Libertyville, IL), Tripathi; Rakesh L. (Palatine, IL), Collins; Christine A. (Skokie, IL), Cohen; Daniel E. (Highland Park, IL), Bernstein; Barry M. (Mequon, WI)
Assignee: AbbVie Inc. (North Chicago, IL)
Application Number:13/412,167
Patent Claim Types:
see list of patent claims
Use;

Drugs Protected by US Patent 9,044,480

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Abbvie Inc VIEKIRA XR dasabuvir sodium; ombitasvir; paritaprevir; ritonavir TABLET, EXTENDED RELEASE;ORAL 208624-001 Jul 22, 2016 RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT OF HCV INFECTION USING PARITAPREVIR ➤ Sign Up
Abbvie Inc VIEKIRA PAK (COPACKAGED) dasabuvir sodium ; ombitasvir; paritaprevir; ritonavir TABLET, TABLET;ORAL 206619-001 Dec 19, 2014 RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT OF HCV INFECTION USING PARITAPREVIR ➤ Sign Up
Abbvie Inc TECHNIVIE ombitasvir; paritaprevir; ritonavir TABLET;ORAL 207931-001 Jul 24, 2015 RX Yes Yes ➤ Sign Up ➤ Sign Up TREATMENT OF HCV INFECTION USING PARITAPREVIR ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Healthtrust
Cerilliant
Chubb
QuintilesIMS
Boehringer Ingelheim
Queensland Health
Baxter
AstraZeneca
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.